EBS compared with PBYI: revenue, margins and what each company keeps, and the suppliers and customers both name

EBSEmergent BioSolutions Inc.

Mkt capRevenueRevenue

PBYIPuma Biotechnology, Inc.

Mkt capRevenueRevenue

Compare

EBSEmergent BioSolutions Inc.

PBYIPuma Biotechnology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

EBS

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.3%▼−29.58%×2.07

Q1 FY26±17.3%▲+2.92%×0.17

Feb 27 '26±23.5%▼−26.58%×1.13

Oct 30 '25±23.1%▲+36.60%×1.58

PBYI

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±45.0%▲+9.73%×0.22

May 8 '26±42.0%▲+3.17%×0.08

= impliedEBS realized, solidPBYI realized, hatchedOne scale, both sides: full bar = 46%× = |realized| ÷ impliedSource: market data

Q1 FY26

±21.7%

▼−25.00%

×1.15

Q3 FY25±18.4%▲+22.24%×1.21

EBSEmergent BioSolutions Inc.

6.42▼−5.73%· post 5.25

Mkt cap$330.2MRevenue$234MQ2 FY26Revenue$743MFY25

PBYIPuma Biotechnology, Inc.

10.42▼−0.22%· post 10.17

ClosedNov 2 '26

Mkt cap$538.9MRevenue$57MQ2 FY26Revenue$228MFY25

Compare

ClosedNov 2 '26

EBSEmergent BioSolutions Inc.

PBYIPuma Biotechnology, Inc.

6.42▼−5.73%post 5.25

Price

10.42▼−0.22%post 10.17

$330.2M

Mkt cap

$538.9M

Q2 FY26$234M

Revenue

$57MQ2 FY26

FY25$743M

Revenue

$228MFY25

EBS6.42▼−5.73%vsPBYI10.42▼−0.22%ClosedNov 2 '26